Zoll takes on Medtronic in the defibrillator market
This article was originally published in Clinica
Executive Summary
People do not have their cardiac arrests near the equipment, you need to bring the equipment to the patient, portability is important," said Richard Packer, president and CEO of Zoll Medical. The company's M series external defibrillator is a third the size and half the weight of products from leading competitors. It is also the only such product with an FDA-approved efficacy claim.